Mylan Reveals First Steps For Viatris As Key Date Approaches

Q3 Results Published, Mylan’s Final Earnings Update

Businessman draws a statistical trend line
Details of Viatris' strategy will be provided at an Investor Day in Q1 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business